You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

ABBV-066

Showing 1 - 25 of 142
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Crohn's Disease Trial (Risankizumab)

Not yet recruiting
  • Crohn's Disease
  • (no location specified)
Aug 10, 2023

Genital Psoriasis, Scalp Psoriasis Trial (Risankizumab, Placebo for Risankizumab)

Not yet recruiting
  • Genital Psoriasis
  • Scalp Psoriasis
  • (no location specified)
Jul 24, 2023

Crohn's Disease Trial (Risankizumab SC, Placebo for risankizumab)

Not yet recruiting
  • Crohn's Disease
  • Risankizumab SC
  • Placebo for risankizumab
  • (no location specified)
Sep 26, 2023

Healthy Volunteers Trial in Shanghai (Risankizumab)

Completed
  • Healthy Volunteers
  • Shanghai, Shanghai, China
    Shanghai Xuhui Central Hospital /ID# 212830
Mar 3, 2022

Juvenile Psoriatic Arthritis Trial (Adalimumab, Risankizumab)

Not yet recruiting
  • Juvenile Psoriatic Arthritis
  • (no location specified)
Oct 20, 2023

Healthy Volunteers Trial in Grayslake (risankizumab)

Completed
  • Healthy Volunteers
  • Grayslake, Illinois
    Acpru /Id# 165737
Mar 9, 2022

Psoriasis Trial (risankizumab, adalimumab, for risankizumab)

Completed
Has Results
  • Psoriasis
  • (no location specified)
Jul 28, 2021

Healthy Volunteers Trial in Grayslake, Austin (Risankizumab)

Completed
  • Healthy Volunteers
  • Grayslake, Illinois
  • +1 more
Mar 9, 2022

Psoriasis Trial (risankizumab, for risankizumab, ustekinumab)

Completed
Has Results
  • Psoriasis
  • (no location specified)
Jul 28, 2021

Healthy Volunteers Trial in Cypress (Risankizumab, Placebo)

Completed
  • Healthy Volunteers
  • Cypress, California
    Altasciences Clinical Los Angeles, Inc /ID# 164197
Mar 23, 2022

Psoriasis Trial (risankizumab, ustekinumab, for risankizumab)

Completed
Has Results
  • Psoriasis
  • (no location specified)
Jul 28, 2021

Ulcerative Colitis (UC), Crohn's Disease Trial in Germany, Israel, United States (Risankizumab, Cytochrome P450 (CYP)

Completed
  • Ulcerative Colitis (UC)
  • Crohn's Disease
  • Coronado, California
  • +5 more
Oct 20, 2022

Psoriasis Trial in Japan (risankizumab)

Completed
Has Results
  • Psoriasis
  • Nagoya-shi, Aichi, Japan
  • +8 more
Nov 16, 2021

Psoriasis Trial in Brazil (risankizumab, methotrexate)

Completed
  • Psoriasis
  • Curitiba, Parana, Brazil
  • +10 more
Nov 29, 2021

Psoriasis Trial (Risankizumab)

Completed
Has Results
  • Psoriasis
  • (no location specified)
Oct 21, 2019

Psoriasis Trial in Russian Federation (risankizumab, for rizankizumab)

Completed
  • Psoriasis
  • Krasnodar, Krasnodarskiy Kray, Russian Federation
  • +5 more
Jan 22, 2021

Crohn Disease Trial in Worldwide (Risankizumab 600 mg IV, Risankizumab 180 mg SC)

Completed
Has Results
  • Crohn Disease
  • Risankizumab 600 mg IV
  • Risankizumab 180 mg SC
  • Chevy Chase, Maryland
  • +27 more
Apr 9, 2020

Psoriasis Trial (Risankizumab, Placebo)

Completed
Has Results
  • Psoriasis
  • (no location specified)
Sep 25, 2019

Psoriasis Trial in Worldwide (Risankizumab)

Enrolling by invitation
  • Psoriasis
  • Fountain Valley, California
  • +36 more
Jan 24, 2023

Arthritis, Psoriatic Trial (risankizumab, for risankizumab)

Completed
Has Results
  • Arthritis, Psoriatic
  • (no location specified)
May 28, 2019

Psoriasis Trial in United States (Risankizumab, Autoinjector)

Completed
Has Results
  • Psoriasis
  • Glendale, Arizona
  • +25 more
Apr 19, 2021

Palmoplantar Pustulosis (PPP) Trial in Japan (Risankizumab, Placebo)

Active, not recruiting
  • Palmoplantar Pustulosis (PPP)
  • Ichinomiya-shi, Aichi, Japan
  • +38 more
Mar 1, 2022

Psoriasis Trial in Worldwide (Risankizumab, Placebo for Risankizumab)

Active, not recruiting
  • Psoriasis
  • Glendale, Arizona
  • +54 more
Mar 2, 2022

Psoriasis Trial in Worldwide (Risankizumab, Apremilast)

Active, not recruiting
  • Psoriasis
  • Birmingham, Alabama
  • +54 more
Jan 25, 2022

Crohn Disease Trial (risankizumab IV, risankizumab SC, Placebo)

Completed
Has Results
  • Crohn Disease
  • risankizumab IV
  • +2 more
  • (no location specified)
Oct 25, 2018